Dana N - Search Results

1

The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies.

Rahimi A, Malakoutikhah Z, Rahimmanesh I, Ferns GA, Nedaeinia R, Ishaghi SMM, Dana N, Haghjooy Javanmard S. Rahimi A, et al. Among authors: dana n. Cancer Cell Int. 2023 Dec 6;23(1):312. doi: 10.1186/s12935-023-03134-y. Cancer Cell Int. 2023. PMID: 38057843 Free PMC article. Review.

2

Leptin signaling in breast cancer and its crosstalk with peroxisome proliferator-activated receptors α and γ.

Dana N, Ferns GA, Nedaeinia R, Haghjooy Javanmard S. Dana N, et al. Clin Transl Oncol. 2023 Mar;25(3):601-610. doi: 10.1007/s12094-022-02988-4. Epub 2022 Nov 8. Clin Transl Oncol. 2023. PMID: 36348225 Review.

3

The dual role of Nrf2 in melanoma: a systematic review.

Malakoutikhah Z, Mohajeri Z, Dana N, Haghjooy Javanmard S. Malakoutikhah Z, et al. Among authors: dana n. BMC Mol Cell Biol. 2023 Feb 6;24(1):5. doi: 10.1186/s12860-023-00466-5. BMC Mol Cell Biol. 2023. PMID: 36747120 Free PMC article.

4

Crosstalk between Peroxisome Proliferator-Activated Receptors and Toll-Like Receptors: A Systematic Review.

Dana N, Vaseghi G, Haghjooy Javanmard S. Dana N, et al. Adv Pharm Bull. 2019 Feb;9(1):12-21. doi: 10.15171/apb.2019.003. Epub 2019 Feb 21. Adv Pharm Bull. 2019. PMID: 31011554 Free PMC article. Review.

5

PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling.

Dana N, Vaseghi G, Haghjooy Javanmard S. Dana N, et al. J Pharm Pharm Sci. 2019;22(1):418-423. doi: 10.18433/jpps30626. J Pharm Pharm Sci. 2019. PMID: 31509504 Free article.

6

Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer In Vitro.

Dana N, Vaseghi G, Haghjooy Javanmard S. Dana N, et al. Adv Pharm Bull. 2020 Jul;10(3):458-463. doi: 10.34172/apb.2020.056. Epub 2020 May 11. Adv Pharm Bull. 2020. PMID: 32665906 Free PMC article.

7

Cancer Occurrence as the Upcoming Complications of COVID-19.

Rahimmanesh I, Shariati L, Dana N, Esmaeili Y, Vaseghi G, Haghjooy Javanmard S. Rahimmanesh I, et al. Among authors: dana n. Front Mol Biosci. 2022 Jan 28;8:813175. doi: 10.3389/fmolb.2021.813175. eCollection 2021. Front Mol Biosci. 2022. PMID: 35155571 Free PMC article. Review.

8

A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma.

Rahimi A, Esmaeili Y, Dana N, Dabiri A, Rahimmanesh I, Jandaghian S, Vaseghi G, Shariati L, Zarrabi A, Haghjooy Javanmard S, Cordani M. Rahimi A, et al. Among authors: dana n. Eur J Pharm Sci. 2023 Aug 1;187:106476. doi: 10.1016/j.ejps.2023.106476. Epub 2023 May 24. Eur J Pharm Sci. 2023. PMID: 37236377 Free article. Review.

9

The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo.

Dana N, Haghjooy Javanmard S, Vaseghi G. Dana N, et al. Clin Transl Oncol. 2020 Apr;22(4):486-494. doi: 10.1007/s12094-019-02150-7. Epub 2019 Jun 7. Clin Transl Oncol. 2020. PMID: 31175545

10

Effect of Anti-Podoplanin on Malignant Glioma Cell Viability, Invasion and Tumor Cell-Induced Platelet Aggregation.

Gharahkhani R, Pourhadi M, Mirdamadi NS, Dana N, Rafiee L, Nedaeinia R, Javanmard SH. Gharahkhani R, et al. Among authors: dana n. Arch Med Res. 2022 Jul;53(5):461-468. doi: 10.1016/j.arcmed.2022.05.003. Epub 2022 May 20. Arch Med Res. 2022. PMID: 35599058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page